Henshaw Capital’s Inspire Medical Systems INSP Stock Holding History

Henshaw Capital’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,188	Closed	-$236K	–	284
2023 Q3	$236K	Buy	1,188 +274	+30%	+$69.1K	0.01%	257
2023 Q2	$297K	Sell	914 -781	-46%	-$223K	0.02%	184
2023 Q1	$397K	Hold	1,695	–	–	0.02%	144
2022 Q4	$427K	Hold	1,695	–	–	0.03%	133
2022 Q3	$301K	Buy	1,695 +158	+10%	+$31.8K	0.02%	203
2022 Q2	$281K	Hold	1,537	–	–	0.02%	233
2022 Q1	$395K	Hold	1,537	–	–	0.02%	196
2021 Q4	$354K	Hold	1,537	–	–	0.02%	224
2021 Q3	$358K	Buy	+1,537	New	+$321K	0.02%	217

Other funds holding INSP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Henshaw Capital's INSP Position: Q4 2023 in Review

Henshaw Capital sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 1,188 shares — an estimated $236K sold.

Henshaw Capital first reported a position in INSP in Q3 2021 and held it in 9 quarters. The position peaked at $427K in Q4 2022. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

Henshaw Capital reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
Henshaw Capital sold 1,188 Inspire Medical Systems shares in Q4 2023, an estimated $236K.
Henshaw Capital first reported a position in Inspire Medical Systems in Q3 2021 and held it in 9 quarters.
Henshaw Capital's Inspire Medical Systems position peaked at $427K in Q4 2022.
343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Henshaw Capital's 13F filing for Q4 2023, filed 28 May 2026.